TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Sarcopenia Treatment Market - Key Industry Dynamics

4.1 North America Sarcopenia Treatment Market - Key Industry Dynamics

4.2 Market Drivers

4.2.1 Upsurge in Geriatric Population

4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults

4.3 Key Market Restraints:

4.3.1 Unavailability of Direct Interventions

4.4 Key Market Opportunities:

4.4.1 Products in Clinical Trial Phases

4.5 Future Trends:

4.5.1 Rising Awareness About Sarcopenia

4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - North America Market Analysis

5.1 North America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

5.2 North America Sarcopenia Treatment Market Forecast and Analysis

6. North America Sarcopenia Treatment Market Analysis - By Treatment Type

6.1 Vitamin D and Calcium Supplement

6.1.1 Overview

6.1.2 Vitamin D and Calcium Supplement : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.2 Protein Supplement

6.2.1 Overview

6.2.2 Protein Supplement : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.3 Vitamin B12 Supplement

6.3.1 Overview

6.3.2 Vitamin B12 Supplement: North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. North America Sarcopenia Treatment Market Analysis - By Distribution Channel

7.1 Pharmacies

7.1.1 Overview

7.1.2 Pharmacies : North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

7.2 Retail Channels

7.2.1 Overview

7.2.2 Retail Channels : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.3 Online Channels

7.3.1 Overview

7.3.2 Online Channels : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others : North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. North America Sarcopenia Treatment Market - Country Analysis

8.1 North America

8.1.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.2 United States Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.2.1 United States Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.2.2 United States Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.3 Canada Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.3.1 Canada Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.3.2 Canada Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.4 Mexico Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.4.1 Mexico Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.4.2 Mexico Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

9.1 Overview

9.2 Growth Strategies in the Sarcopenia Treatment Market

9.3 Inorganic Growth Strategies

9.3.1 Overview

9.4 Organic Growth Strategies

9.4.1 Overview

10. Company Profiles

10.1 Abbott Laboratories

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Bayer AG

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Metagenics LLC

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Nestle Health Science SA

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Novartis AG

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 Pfizer Inc

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Sanofi SA

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Amway Corp

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 GSK Plc

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Products and Services

10.9.4 Financial Overview

10.9.5 SWOT Analysis

10.9.6 Key Developments

10.10 Makers Nutrition LLC

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Products and Services

10.10.4 Financial Overview

10.10.5 SWOT Analysis

10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

List of Tables

Table 1. North America Sarcopenia Treatment Market Segmentation

Table 2. Sarcopenia Drug Under Clinical Development

Table 3. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

Table 4. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - By Treatment Type

Table 5. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel

Table 6. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country

Table 7. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 8. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 9. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 10. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 11. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 12. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 13. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market

Table 14. Recent Organic Growth Strategies in the Sarcopenia Treatment Market

Table 15. Glossary of Terms, Sarcopenia Treatment Market

List of Figures

Figure 1. North America Sarcopenia Treatment Market Segmentation, By Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. North America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

Figure 4. North America Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030

Figure 5. Vitamin D and Calcium Supplement : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 6. Protein Supplement : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 7. Vitamin B12 Supplement: North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 8. Others : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 9. North America Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030

Figure 10. Pharmacies : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 11. Retail Channels : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 12. Online Channels : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 13. Others : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 14. North America Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)

Figure 15. North America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 16. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 17. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 18. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 19. Growth Strategies in the Sarcopenia Treatment Market